Milassin Ágnes, Sejben Anita, Tiszlavicz László, Reisz Zita, Lázár György, Szűcs Mónika, Bor Renáta, Bálint Anita, Rutka Mariann, Szepes Zoltán, Nagy Ferenc, Farkas Klaudia, Molnár Tamás
Ágnes Milassin, Renáta Bor, Anita Bálint, Mariann Rutka, Zoltán Szepes, Ferenc Nagy, Klaudia Farkas, Tamás Molnár, First Department of Internal Medicine, University of Szeged, 6720 Szeged, Hungary.
World J Gastrointest Surg. 2017 Jul 27;9(7):167-173. doi: 10.4240/wjgs.v9.i7.167.
To evaluate the presence of submucosal and myenteric plexitis and its role in predicting postoperative recurrence.
Data from all patients who underwent Crohn's disease (CD)-related resection at the University of Szeged, Hungary between 2004 and 2014 were analyzed retrospectively. Demographic data, smoking habits, previous resection, treatment before and after surgery, resection margins, neural fiber hyperplasia, submucosal and myenteric plexitis were evaluated as possible predictors of postoperative recurrence. Histological samples were analyzed blinded to the postoperative outcome and the clinical history of the patient. Plexitis was evaluated based on the appearance of the most severely inflamed ganglion or nerve bundle. Patients underwent regular follow-up with colonoscopy after surgery. Postoperative recurrence was defined on the basis of endoscopic and clinical findings, and/or the need for additional surgical resection.
One hundred and four patients were enrolled in the study. Ileocecal, colonic, and small bowel resection were performed in 73.1%, 22.1% and 4.8% of the cases, respectively. Mean disease duration at the time of surgery was 6.25 years. Twenty-six patients underwent previous CD-related surgery. Forty-three point two percent of the patients were on 5-aminosalicylate, 20% on corticosteroid, 68.3% on immunomodulant, and 4% on anti-tumor necrosis factor-alpha postoperative treatment. Postoperative recurrence occurred in 61.5% of the patients; of them 39.1% had surgical recurrence. 92.2% of the recurrences developed within the first five years after the index surgery. Mean disease duration for endoscopic relapse was 2.19 years. The severity of submucosal plexitis was a predictor of the need for second surgery (OR = 1.267, 95%CI: 1.000-1.606, = 0.050). Female gender (OR = 2.21, 95%CI: 0.98-5.00, = 0.056), stricturing disease behavior (OR = 3.584, 95%CI: 1.344-9.559, = 0.011), and isolated ileal localization (OR = 2.671, 95%CI: 1.033-6.910, = 0.043) were also predictors of postoperative recurrence. No association was revealed between postoperative recurrence and smoking status, postoperative prophylactic treatment and the presence of myenteric plexitis and relapse.
The presence of severe submucosal plexitis with lymphocytes in the proximal resection margin is more likely to result in postoperative relapse in CD.
评估黏膜下和肌间神经丛炎的存在情况及其在预测术后复发中的作用。
回顾性分析2004年至2014年间在匈牙利塞格德大学接受克罗恩病(CD)相关切除术的所有患者的数据。评估人口统计学数据、吸烟习惯、既往切除术、手术前后治疗、手术切缘、神经纤维增生、黏膜下和肌间神经丛炎,将其作为术后复发的可能预测因素。对组织学样本进行分析时,不了解患者的术后结果和临床病史。根据最严重炎症的神经节或神经束外观评估神经丛炎。患者术后接受结肠镜定期随访。根据内镜和临床检查结果及/或是否需要再次手术来定义术后复发。
104例患者纳入研究。分别有73.1%、22.1%和4.8%的病例进行了回盲部、结肠和小肠切除术。手术时的平均病程为6.25年。26例患者曾接受过与CD相关的手术。43.2%的患者术后接受5-氨基水杨酸治疗,20%接受皮质类固醇治疗,68.3%接受免疫调节剂治疗,4%接受抗肿瘤坏死因子-α治疗。6进行了再次手术。92.2%的复发发生在初次手术后的前五年内。内镜复发的平均病程为2.19年。黏膜下神经丛炎的严重程度是再次手术需求的预测因素(OR = 1.267,95%CI:1.000 - 1.606,P = 0.050)。女性(OR = 2.21,95%CI:0.98 - 5.00,P = 0.056)、狭窄型疾病行为(OR = 3.584,95%CI:1.344 - 9.559,P = 0.011)和孤立性回肠定位(OR = 2.671,95%CI:1.033 - 6.910,P = 0.043)也是术后复发的预测因素。术后复发与吸烟状况、术后预防性治疗以及肌间神经丛炎的存在和复发之间未发现关联。
近端切缘存在伴有淋巴细胞的严重黏膜下神经丛炎更有可能导致CD术后复发。